Identification of differentially expressed miRNAs in BM+ vs. BM- lung cancer samples

ABSTRACT: Brain metastasis (BM) can affect up to 25% of non-small cell lung cancer (NSCLC) patients during their lifetime. Efforts to characterize patients that will develop BM have been fairly disappointing. Small non-coding microRNAs (miRNAs) regulate the expression of target mRNAs by repressing their translation or regulating their sequence-specific degradation. miRNAs play a role in regulating a variety of targets and, consequently, multiple pathways, which makes them a powerful tool to be exploited for early detection of disease, risk assessment, and prognosis. In this study, we investigated miRNAs that may serve as biomarkers to differentiate between NSCLC patients with and without BM. miRNA microarray profiling was performed on samples from clinically matched NSCLC from patients with BM (

ORGANISM(S): Homo sapiens

SUBMITTER: Ross Julianna 

PROVIDER: S-ECPF-GEOD-23019 | biostudies-other |

REPOSITORIES: biostudies-other